Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Why the cell-free fetal DNA test is a game-changer

Danielle Jones, MD
Conditions
November 2, 2017
Share
Tweet
Share

As a practicing OB/GYN, I feel lucky to be working in a field so full of promise and with space for advancement of medical technology. Although prospects of improved fetal imaging, cervical cancer prevention, and techniques of minimally invasive surgery are game-changing, new discoveries in the genetics arena of our field strike me as simply incredible.

Prenatal genetic testing has only been reasonably available to mothers since about 1970, and at that time was limited to invasive testing using amniocentesis, which carried significant risks. Although “amnio” still has a place in obstetrics, the availability of bedside ultrasound has improved the safety profile greatly.

Following amniocentesis, the need for a procedure which allowed for evaluation at an earlier gestational age pushed us forward and helped bring chorionic villus sampling (CVS) to the forefront of obstetrics care in the 80s.

Unfortunately, both those procedures are invasive and carry various risks to both mom and baby. While both procedures are still used today, most feel the associated risks are reasonable only in high-risk populations: those that carry a relatively high risk of conceiving a baby with a severe genetic defect. This fact left a huge group of low-risk women with no real options for prenatal genetic screening.

The 90s brought about another era of genetic advancement by introducing serum screening comprised of various hormones and serum markers which could be analyzed with a simple maternal blood draw. The extensive research required to develop such screening tests is incredible. Although these screens minimize risks compared to amnio and CVS, they sacrifice the actual chromosome-detection offered by invasive testing. Serum screening is important and helpful, but can provide only a risk analysis and not a true diagnosis.

In the past 10 to 15 years, a new player has come onto the field: cell-free fetal DNA (cffDNA). Nothing short of incredible, cffDNA offers a minimally invasive test requiring only a maternal blood sample to evaluate fetal DNA (present in maternal circulation) for genetic aneuploidy. By identifying that fetal DNA was not only present in the maternal circulation, but that it could be isolated and evacuated, the medical researchers responsible for these discoveries revolutionized prenatal diagnosis. Although most geneticists and physicians still recommend “definitive diagnosis” with invasive methods, this type of screening can provide a relatively accurate look at a fetal chromosomal makeup as early as ten weeks gestation.

It’s easy to see where we’ve come from, but identifying where we’re going is more difficult. As recent as 25 years ago very few physicians would have been optimistic that fetal DNA was even present in maternal circulation in large enough amounts to actually isolate. However, a forward-thinking researcher managed to not only isolate it, but to develop an accurate test for chromosomal analysis which could be expanded into clinical use.

Although not indicated for everyone, cffDNA has been an amazing game-changer. The future is unpredictable, but I am hopeful that it holds promise of minimally invasive prenatal diagnosis for more than just potentially lethal anomalies. Improvements in ultrasound, genetic screening and risk-analysis could open the door to a future where parents have freedom to anticipate and plan for needs beyond just major aneuploidy.

Danielle Jones is an obstetrician-gynecologist. This article originally appeared in the American Resident Project.

Image credit: Shutterstock.com

Prev

Seeds, popcorn, and nuts in diverticulitis: fact and fiction

November 2, 2017 Kevin 0
…
Next

“My mom is a doctor; my dad is a dad.”

November 2, 2017 Kevin 4
…

Tagged as: OB/GYN

Post navigation

< Previous Post
Seeds, popcorn, and nuts in diverticulitis: fact and fiction
Next Post >
“My mom is a doctor; my dad is a dad.”

ADVERTISEMENT

More by Danielle Jones, MD

  • How to care for patients who are personal health researchers

    Danielle Jones, MD
  • A day in the life of an OB/GYN chief resident

    Danielle Jones, MD
  • Why patient education needs to be more YouTube-friendly

    Danielle Jones, MD

Related Posts

  • Physicians who don’t play the social media game may be left behind

    Xrayvsn, MD
  • A new rule that could be a game changer for health care

    Elisabeth Rosenthal, MD
  • How sickle cell anemia influences a medical school journey

    Bianca Bowden
  • Physicians and patients are now pawns in a political game

    Nicole M. King, MD
  • Skin-in-the-game doesn’t have to be scary

    Ronald Dixon, MD
  • What health care can learn from Game of Thrones

    Robert Pearl, MD

More in Conditions

  • Facing terminal cancer as a doctor and mother

    Kelly Curtin-Hallinan, DO
  • Why doctors must stop ignoring unintentional weight loss in patients with obesity

    Samantha Malley, FNP-C
  • Why hospitals are quietly capping top doctors’ pay

    Dennis Hursh, Esq
  • Why point-of-care ultrasound belongs in emergency department triage

    Resa E. Lewiss, MD and Courtney M. Smalley, MD
  • Why PSA levels alone shouldn’t define your prostate cancer risk

    Martina Ambardjieva, MD, PhD
  • Reframing chronic pain and dignity: What a pain clinic teaches us about MAiD and chronic suffering

    Olumuyiwa Bamgbade, MD
  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • America’s ER crisis: Why the system is collapsing from within

      Kristen Cline, BSN, RN | Conditions
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • How early meetings and after-hours events penalize physician-mothers

      Samira Jeimy, MD, PhD and Menaka Pai, MD | Physician
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
  • Recent Posts

    • Beyond burnout: Understanding the triangle of exhaustion [PODCAST]

      The Podcast by KevinMD | Podcast
    • Facing terminal cancer as a doctor and mother

      Kelly Curtin-Hallinan, DO | Conditions
    • Online eye exams spark legal battle over health care access

      Joshua Windham, JD and Daryl James | Policy
    • FDA delays could end vital treatment for rare disease patients

      G. van Londen, MD | Meds
    • Pharmacists are key to expanding Medicaid access to digital therapeutics

      Amanda Matter | Meds
    • Why ADHD in women requires a new approach [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • America’s ER crisis: Why the system is collapsing from within

      Kristen Cline, BSN, RN | Conditions
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • How early meetings and after-hours events penalize physician-mothers

      Samira Jeimy, MD, PhD and Menaka Pai, MD | Physician
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
  • Recent Posts

    • Beyond burnout: Understanding the triangle of exhaustion [PODCAST]

      The Podcast by KevinMD | Podcast
    • Facing terminal cancer as a doctor and mother

      Kelly Curtin-Hallinan, DO | Conditions
    • Online eye exams spark legal battle over health care access

      Joshua Windham, JD and Daryl James | Policy
    • FDA delays could end vital treatment for rare disease patients

      G. van Londen, MD | Meds
    • Pharmacists are key to expanding Medicaid access to digital therapeutics

      Amanda Matter | Meds
    • Why ADHD in women requires a new approach [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...